Madrigal Pharmaceuticals (MDGL) Q2 2025 Earnings

May 1Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-7.54
-5.93
-4.32
-2.71

Details

Expected EPS
-3.748533
Actual EPS
-3.32
Surprise EPS
0.43
Surprise Percent
+11.43%

Description

⁨Madrigal Pharmaceuticals⁩ (⁦MDGL⁩) has reported earnings of ⁦-3.32⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts